Join Sam Matthew, an independent consultant at Inago Life Sciences specializing in expedited publications, alongside Raghuraj Putage, the function head of medical communications at Inago. They delve into the critical role of expedited publications during health emergencies like COVID-19, emphasizing the balance between speed and research integrity. The duo discusses the transformative impact these publications have on therapies such as gene and CAR T-cell therapies and the ethical challenges faced, advocating for transparency in the fast-paced pharmaceutical landscape.
